Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03246126 · ClinicalTrials.gov registry record · NA
Visceral Manifold Study for the Repair of Thoracoabdominal Aortic Aneurysms
A NA study, sponsored by NYU Langone Health.
- Completed
- Registry status
- NA
- Development phase
- 17
- Enrollment target
NCT03246126 is a NA study that has completed, run by NYU Langone Health. The registered enrollment target is 17 participants.
The verdict
NCT03246126, a NA study, has completed, sponsored by NYU Langone Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 17 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the use of an investigational device called the ValiantTM Visceral Manifold Thoracoabdominal Stent Graft System for the repair of thoracoabdominal aortic aneurysms (TAAA), which is a balloon-like bulge in the aorta (major artery leading away from your heart) that originates in your chest and extends to your abdomen and also includes the branch arteries that supply blood to the liver, spleen, intestine, kidneys and other organs in your abdomen. The word "investigational" means the device is still being tested and is not approved by the Food and Drug Administration (FDA) for sale in the United States.
Interventions
- DEVICE Valiant™Thoracoabdominal Stent Graft System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 17 participants |
| Start Date | 2017-11-01 |
| Est. Completion | 2023-06-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03246126
The ClinicalTrials.gov registry entry for NCT03246126 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 17 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Valiant™Thoracoabdominal Stent Graft System is the first listed.
NCT03246126 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03246126 about?
NCT03246126 is a clinical study titled "Visceral Manifold Study for the Repair of Thoracoabdominal Aortic Aneurysms". The purpose of this study is to evaluate the use of an investigational device called the ValiantTM Visceral Manifold Thoracoabdominal Stent Graft System for the repair of thoracoabdominal aortic aneurysms (TAAA), which is a balloon-like bulge in the aorta (major artery leading away from your heart) ...
What is the current status of trial NCT03246126?
This trial is currently completed. It is a NA study. The enrollment target is 17 participants. The study started on 2017-11-01. Estimated completion is 2023-06-07.
What interventions are being tested in trial NCT03246126?
The interventions under investigation include: Valiant™Thoracoabdominal Stent Graft System (DEVICE).
Who is sponsoring clinical trial NCT03246126?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.